These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 7530986)

  • 1. Measurement of urinary beta core fragment of human chorionic gonadotrophin in women with vulvovaginal malignancy and its prognostic significance.
    Carter PG; Iles RK; Neven P; Ind TE; Shepherd JH; Chard T
    Br J Cancer; 1995 Feb; 71(2):350-3. PubMed ID: 7530986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The purification and development of a radioimmunoassay for beta-core fragment of human chorionic gonadotrophin in urine: application as a marker of gynaecological cancer in premenopausal and postmenopausal women.
    Lee CL; Iles RK; Shepherd JH; Hudson CN; Chard T
    J Endocrinol; 1991 Sep; 130(3):481-9. PubMed ID: 1719119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prognostic significance of urinary beta core fragment in premenopausal women with carcinoma of the cervix.
    Carter PG; Iles RK; Neven P; Ind TE; Shepherd JH; Chard T
    Gynecol Oncol; 1994 Nov; 55(2):271-6. PubMed ID: 7525427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urinary concentration of human chorionic gonadotrophin and its fragments as a prognostic marker in bladder cancer.
    Iles RK; Persad R; Trivedi M; Sharma KB; Dickinson A; Smith P; Chard T
    Br J Urol; 1996 Jan; 77(1):61-9. PubMed ID: 8653319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of urinary beta-core fragment of human chorionic gonadotropin as a new tumor marker of lung cancer.
    Yoshimura M; Nishimura R; Murotani A; Miyamoto Y; Nakagawa T; Hasegawa K; Koizumi T; Shii K; Baba S; Tsubota N
    Cancer; 1994 Jun; 73(11):2745-52. PubMed ID: 7514953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary chorionic gonadotropin subunits and beta-core in nonpregnant women. A study of benign and malignant gynecologic disorders.
    Neven P; Iles RK; Lee CL; Hudson CN; Shepherd JH; Chard T
    Cancer; 1993 Jun; 71(12):4124-30. PubMed ID: 7685240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prognostic significance of beta human chorionic gonadotrophin and its metabolites in women with cervical carcinoma.
    Crawford RA; Iles RK; Carter PG; Caldwell CJ; Shepherd JH; Chard T
    J Clin Pathol; 1998 Sep; 51(9):685-8. PubMed ID: 9930074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary human chorionic gonadotropin free beta-subunit and beta-core fragment: a new marker of gynecological cancers.
    Cole LA; Wang YX; Elliott M; Latif M; Chambers JT; Chambers SK; Schwartz PE
    Cancer Res; 1988 Mar; 48(5):1356-60. PubMed ID: 3342414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Urinary hCG beta-core fragment as a tumor marker for bladder cancer].
    Yamanaka N; Kawabata G; Morisue K; Hazama M; Nishimura R
    Nihon Hinyokika Gakkai Zasshi; 1993 Apr; 84(4):700-6. PubMed ID: 8492514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beta human chorionic gonadotrophin in serum and urine. A marker for metastatic urothelial cancer.
    Iles RK; Jenkins BJ; Oliver RT; Blandy JP; Chard T
    Br J Urol; 1989 Sep; 64(3):241-4. PubMed ID: 2478247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urinary mesothelin provides greater sensitivity for early stage ovarian cancer than serum mesothelin, urinary hCG free beta subunit and urinary hCG beta core fragment.
    Badgwell D; Lu Z; Cole L; Fritsche H; Atkinson EN; Somers E; Allard J; Moore RG; Lu KH; Bast RC
    Gynecol Oncol; 2007 Sep; 106(3):490-7. PubMed ID: 17532030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary gonadotropin fragment measurements in patients with lung and esophageal disease.
    D'Agostino RS; Cole LA; Ponn RB; Stern H; Schwartz PE
    J Surg Oncol; 1992 Mar; 49(3):147-50. PubMed ID: 1548888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The origin of a human chorionic gonadotropin beta-subunit-core fragment excreted in the urine of patients with cancer.
    Papapetrou PD; Nicopoulou SC
    Acta Endocrinol (Copenh); 1986 Jul; 112(3):415-22. PubMed ID: 2428192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of highly sensitive immunoassays to measure human chorionic gonadotropin, its beta-subunit, and beta core fragment in the urine: application to malignancies.
    O'Connor JF; Schlatterer JP; Birken S; Krichevsky A; Armstrong EG; McMahon D; Canfield RE
    Cancer Res; 1988 Mar; 48(5):1361-6. PubMed ID: 2449279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urinary gonadotropin fragment, a new tumor marker. I. Assay development and cancer specificity.
    Nam JH; Cole LA; Chambers JT; Schwartz PE
    Gynecol Oncol; 1990 Mar; 36(3):383-90. PubMed ID: 2318449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved methods for detecting beta-core in normal and cancer patient urines.
    Tanaka A; Cole LA
    Clin Chem; 1994 Dec; 40(12):2317-8. PubMed ID: 7988019
    [No Abstract]   [Full Text] [Related]  

  • 17. [Development of highly sensitive enzyme immunoassay to measure urinary beta-core fragment in patients with gynecological cancer].
    Nishimura R; Kobayashi K; Katsuno M; Kobayashi T
    Nihon Sanka Fujinka Gakkai Zasshi; 1990 Feb; 42(2):143-8. PubMed ID: 1690253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The measurement of urinary beta core fragment in conjunction with serum CA125 does not aid the differentiation of malignant from benign pelvic masses.
    Carter PG; Iles RK; Neven P; Davies AP; Shepherd JH; Chard T
    Gynecol Oncol; 1993 Dec; 51(3):368-71. PubMed ID: 8112647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of beta human chorionic gonadotrophin in blood serum of patients with urinary bladder tumours.
    Dobrowolski ZF; Byrska B; Dolezal M
    Int Urol Nephrol; 1994; 26(3):301-6. PubMed ID: 7525501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Assessment of urinary beta-core fragment of hCG as a tumor marker of cervical cancer].
    Kinugasa M; Nishimura R; Hasegawa K; Okamura M; Kimura A; Ohtsu F; Takeuchi K
    Nihon Sanka Fujinka Gakkai Zasshi; 1992 Feb; 44(2):188-94. PubMed ID: 1545171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.